🇺🇸 FDA
Company

NEKTAR

NEKTAR THERAPEUTICS

NKTR pharma USA

Quick answer

NEKTAR is a pharma company (NKTR) headquartered in SAN FRANCISCO, CA, USA with 24 tracked pipeline programs.

Pipeline (24)

project

Amikacin Inhalation Solution (BAY41-6551)

Pneumonia, Bacterial

Phase 3 · small_molecule · completed

1 trials project

Bempegaldesleukin

Melanoma

Phase 3 · mab · terminated

1 trials project

Bempegaldesleukin

Metastatic Head and Neck Cancer

Phase 3 · small_molecule · terminated

1 trials project

Inhaled Human Insulin

Diabetes Mellitus, Type 2

Phase 3 · small_molecule · completed

1 trials project

NKTR-102

Locally Recurrent Breast Cancer

Phase 3 · small_molecule · completed

1 trials project

NKTR-102

Metastasis

Phase 3 · small_molecule · completed

1 trials project

NKTR-181 BID tablets

Low Back Pain

Phase 3 · small_molecule · completed

2 trials project

NKTR-214

Melanoma

Phase 3 · mab · completed

1 trials project

NKTR-255 at 1.5 µg/kg

Non-Hodgkin Lymphoma

Phase 3 · small_molecule · terminated

1 trials project

Nivolumab

Bladder Cancer

Phase 3 · mab · completed

1 trials project

bempegaldesleukin

Renal Cell Carcinoma

Phase 3 · mab · terminated

1 trials project

Amikacin (BAY41-6551)

Pneumonia

Phase 2 · small_molecule · completed

1 trials project

Amikacin inhalation solution (BAY41-6551)

Pneumonia

Phase 2 · small_molecule · completed

1 trials project

Avelumab

Locally Advanced or Metastatic Urothelial Carcinoma

Phase 2 · small_molecule · active

1 trials project

Bempegaldesleukin

Urinary Bladder Neoplasm

Phase 2 · mab · completed

1 trials project

Dose Escalation Doublet: Combination of NKTR-214 + nivolumab

Melanoma

Phase 2 · small_molecule · completed

1 trials project

Dronabinol MDI

Migraine With Aura

Phase 2 · small_molecule · completed

1 trials project

Etirinotecan pegol

Anaplastic Astrocytomas

Phase 2 · small_molecule · completed

1 trials project

LY3471851

Systemic Lupus Erythematosus

Phase 2 · small_molecule · completed

2 trials project

LY3471851

Colitis, Ulcerative

Phase 2 · small_molecule · terminated

1 trials project

NKTR-102

Colorectal Cancer

Phase 2 · small_molecule · completed

1 trials project

NKTR-102

Tumor

Phase 2 · small_molecule · completed

1 trials project

NKTR-102 100 mg/m2

Tumor

Phase 2 · small_molecule · completed

1 trials project

NKTR-102 145 mg/m2

Malignant Solid Tumor

Phase 2 · small_molecule · completed

1 trials

Patents (8)

patent

US 12324828

Conjugates of a factor VIII moiety having an oxime-containing linkage

Expires Mon Jun 05 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12325708

Adenosine 2 receptor antagonists

Expires Mon Jun 05 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12247059

Conjugates of an IL-2 moiety and a polymer

Expires Mon Mar 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12233104

Combination of an IL-2RBETA-selective agonist and a long-acting IL-15 agonist

Expires Mon Feb 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12214045

Multi-arm polymer conjugates of TLR agonist compounds and related immunotherapeu

Expires Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12054553

Immunotherapeutic tumor treatment method

Expires Mon Aug 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12036283

Long-acting interleukin-15 receptor agonists and related immunotherapeutic compo

Expires Mon Jul 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12030940

Immunotherapeutic tumor treatment method

Expires Mon Jul 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)